Tiny study checks blood pressure drug in kids
NCT ID NCT05107960
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at how safe and effective the blood pressure drug azilsartan is for children aged 6 to 16 with high blood pressure. Only 5 children took part, and doctors monitored them for side effects and blood pressure changes for up to 12 months. The goal was to gather real-world safety data, not to compare with other treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
azilsartan (Azilva tablets or granules)
What this could lead to
If results are positive, it could confirm that azilsartan is a safe and effective option for managing high blood pressure in children.
What could go wrong
This was a very small study (only 5 children) with no comparison group, so findings may not apply broadly. Side effects are still possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Takeda selected site
Tokyo, Japan